SAFE vs Convertible Notes: The Cap Table Reset Problem

# SAFE vs Convertible Notes: The Cap Table Reset Problem

We recently worked with a Series A-stage founder who discovered something unsettling three weeks before closing her $2M round. The SAFE notes she'd issued to seed investors would convert at a *lower* valuation than the convertible notes from her angel investors—meaning the SAFEs would convert into more equity, diluting her and the convertibles proportionally.

Her lawyer had told her SAFEs were simpler. Her CFO had told her they were cheaper to administer. Nobody had explained that SAFEs and convertible notes create fundamentally different cap table mathematics.

This is the gap we see repeatedly: founders understand the surface differences between these instruments, but they don't grasp how each one *resets your cap table at conversion*. And that reset has profound implications for founder dilution, investor signaling, and your path to Series B.

## The Core Cap Table Problem Nobody Explains

Here's what actually happens when you issue either instrument:

**Convertible notes** sit on your balance sheet as debt until conversion. When they convert, they become equity—but the timing and valuation are predetermined *at issuance*. The conversion is contractually locked.

**SAFE notes** aren't debt at all. They're contractual agreements to issue equity in the future, triggered by specific events (usually a priced round). SAFE notes don't sit on your balance sheet. They exist in a legal gray area—not equity, not debt—until conversion happens.

The problem: **both instruments convert differently depending on market conditions and timing**, and most founders don't model what that means for their actual ownership percentage.

Let's walk through a specific example.

### The Math That Matters

You're a pre-seed founder with a bootstrapped cap table:
- You: 1,000,000 shares (100%)

You raise a SAFE note from an institutional investor: $500K at a $4M valuation cap with a 20% discount.

You raise a convertible note from an angel: $100K at a 10% annual interest rate, converting at your Series A at a 30% discount.

Six months later, you land your Series A at a $10M valuation, raising $2M.

**Here's where cap table math diverges:**

The SAFE converts at the Series A valuation ($10M), applying the 20% discount. The conversion price is $10M × (1 - 0.20) = $8M effective valuation. The SAFE investor gets shares as if they invested at an $8M valuation:
- SAFE investor receives: $500K ÷ ($8M ÷ initial shares) = proportional stake based on $8M valuation

The convertible note converts at the Series A valuation ($10M), applying the 30% discount. The conversion price is $10M × (1 - 0.30) = $7M effective valuation. Plus accrued interest of approximately $5K converts to equity.
- Convertible investor receives: ($100K + $5K accrued interest) ÷ ($7M ÷ initial shares) = proportional stake based on $7M valuation

**The outcome:** The convertible note investor gets a *better* conversion price than the SAFE investor because of the deeper discount. Both dilute you, but they dilute you at *different rates* based on instrument-specific mechanics.

In our experience working with founders, this is where the cap table reset becomes painful. You haven't issued new equity intentionally—you've just converted debt-like instruments into equity using instrument-specific math, and the founder ownership has shifted without an explicit new financing event.

## The Real Problem: Conversion Sequence and Stacking

The cap table reset problem gets worse when you have *multiple SAFEs and convertibles* converting simultaneously—which is most founders' reality.

Consider this scenario we see often:

**Seed round:**
- SAFE from Seed Fund A: $250K at $2M cap, 20% discount
- SAFE from Angel B: $50K at $2M cap, 20% discount
- Convertible from Angel C: $75K at 15% discount, 8% annual interest

**Series A (12 months later at $12M valuation):**
- All three instruments convert simultaneously

Now, the conversion sequence matters:

1. **The discount stacking problem:** Do all three discounts apply to the same $12M valuation? Or does the first conversion establish a new baseline? Different legal interpretations create different cap table outcomes.

2. **The MFN clause collision:** Most SAFEs include an MFN (Most Favored Nation) clause. If your convertible note converts at a deeper discount (say, 30%) than the SAFE's 20%, the SAFE automatically gets the 30% discount too. Now your cap table has shifted again—without a new agreement.

3. **The interest accrual wildcard:** Convertible notes accrue interest. If your convertible note is $75K with 8% annual interest, by the time you hit Series A at 12 months, it's $81K converting into equity. SAFEs don't accrue interest, so there's no equivalent dilution. This creates unequal investor experience for similar-sized instruments.

We had one client whose seed round included three SAFEs and two convertible notes. At Series A conversion, an investor triggered an MFN clause that we'd overlooked. That single clause triggered three additional conversions at better terms, instantly resetting the founder's dilution by 2.3 percentage points. That's real money—and it happened without new capital.

## Cap Table Modeling: The Tool Most Founders Skip

The reason we see founders blindsided by cap table resets is simple: **they're not modeling the conversion scenarios in advance.**

Here's what you should be doing (and most founders aren't):

### 1. **Scenario-based conversion modeling**

Build a cap table model with three columns:
- Current state (pre-Series A)
- Series A scenario 1: $5M valuation
- Series A scenario 2: $15M valuation

For each scenario, calculate:
- How many shares each SAFE and convertible converts into
- What your ownership percentage becomes
- What the implied post-money dilution is

Run this for *every* SAFE and convertible you issue. Most founders have never seen this analysis.

### 2. **Discount comparison matrix**

List every SAFE and convertible with:
- Issue date
- Amount
- Discount percentage
- Valuation cap (SAFEs)
- Interest rate (convertibles)
- MFN clause status

Then identify which investor has the "best" terms. That's your reset baseline. Every other investor will either convert at the same level (via MFN) or worse—affecting their dilution.

### 3. **Conversion trigger mapping**

For SAFEs, the trigger might be:
- Priced Series A round
- IPO
- Acquisition (at a specific valuation threshold)
- Maturation date (2-3 years after issuance)

For convertibles:
- Maturity date (typically 18-24 months)
- Priced round
- Acquisition above a specific valuation

**Different triggers convert at different times.** If a Series A round closes but a convertible note doesn't meet the conversion trigger, it stays as debt on your balance sheet—affecting your balance sheet and future fundraising optionality. This is a cap table reset delay that affects financing strategy.

In our work with [Series A Preparation: The Revenue Proof-of-Concept Problem Founders Miss](/blog/series-a-preparation-the-revenue-proof-of-concept-problem-founders-miss/), we found that founders who didn't model conversion triggers underestimated their actual equity position going into Series A—and therefore overestimated available equity for Series A investors and employee grants.

## The Founder Ownership Trajectory Problem

Here's what bothers us most about the cap table reset problem: **founders often don't realize how much they've already diluted themselves until the conversion happens.**

Let's say you issued:
- 3 SAFEs over 18 months ($250K each at $2M cap, 20% discount)
- 2 convertible notes ($75K each at 15% discount)

You think you've raised $1M from instruments that will convert at Series A.

But here's what you should be thinking:

**At a $10M Series A:**
- Each SAFE at $2M cap with 20% discount converts as if you valued the company at $1.6M. That's *heavily* discounted.
- Total SAFE dilution: approximately 12-15% of your cap table goes to SAFE investors
- Convertible dilution: approximately 2-3% of your cap table

**Before you've even accepted Series A capital, you've diluted yourself by 14-18%.** The Series A round dilutes you further. If Series A raises $2M at $10M valuation, that's ~17% dilution for new investors. Combined with seed dilution, you're looking at 28-32% dilution from seed to Series A.

Most founders we work with estimate 20% total dilution to seed and Series A combined. The actual number is closer to 35-40%. The cap table reset is why.

## What Founders Should Actually Negotiate

If SAFEs and convertible notes both create cap table resets, what should you actually focus on?

### **For SAFEs:**

1. **The valuation cap is your real negotiation point.** A $2M cap means investors get conversion pricing as if the company was worth $2M, even if it's now worth $10M. Lower caps = more dilution to founders. Push for realistic caps based on your likely Series A range.

2. **MFN clauses need careful crafting.** Standard MFN language triggers automatically if any investor gets better terms. This creates cascading cap table resets. Consider negotiating MFN caps—e.g., "MFN applies only if the new discount exceeds the previous discount by >5%." This prevents minor variations from triggering costly resets.

3. **Conversion triggers should align with your timeline.** If you model a Series A in 18 months but your SAFE matures in 2 years, you have a gap. If you miss Series A, the SAFE might convert into your balance sheet on maturation, forcing equity issuance without new capital. Align triggers to realistic financing timelines.

### **For convertible notes:**

1. **Interest rates matter, but not the way you think.** An 8% interest rate sounds reasonable. But over 18 months, that's ~$12K of accrued interest on a $100K note. That extra $12K converts to equity, diluting founders. Negotiate lower interest rates (6% is market) or cap accrued interest at conversion.

2. **Maturity dates create forced conversions.** If your convertible note matures before your Series A closes, you either convert it (forcing equity issuance) or refinance it (more paperwork, more fees). Build 3-6 months of buffer into maturity dates to account for Series A timeline uncertainty.

3. **Conversion discounts should be less aggressive than SAFEs.** SAFEs with 20-25% discounts are standard. Convertible notes with 30%+ discounts are common but punitive. Push for 15-20% range. The extra interest accrual already compensates investors.

## The Strategic Decision Framework

So when should you actually use SAFEs vs. convertible notes?

**Use SAFEs when:**
- You're raising from institutional seed investors who expect standardized terms
- You're raising small amounts ($25K-$250K per check) and want minimal legal friction
- You expect Series A within 18-24 months and want clean conversion mechanics
- You want investors to own equity risk, not debt risk (SAFEs aren't debt)

**Use convertible notes when:**
- You're raising from angels who expect debt-like investor protections
- You expect Series A timeline might be longer (24-36 months) and want maturity certainty
- You want investors to have explicit debt rights (interest, principal repayment if maturity hit without Series A)
- Your legal jurisdiction has issues with SAFE enforceability (rare, but it happens)

**The practical truth:** Most founders use SAFEs because they're simpler. But convertible notes are often better for founders when structured correctly, because the debt mechanics give you more control over conversion timing. In our experience, a well-structured convertible note—with reasonable interest rate, realistic maturity, and moderate discount—can result in *less* founder dilution than an equivalent SAFE if the Series A timeline slips.

But here's where the cap table reset problem becomes critical: **you need to model both instruments with realistic Series A scenarios before committing.** Don't let the legal simplicity of SAFEs override the financial modeling.

## Cap Table Reset Preparation: The Checklist

Before you issue another SAFE or convertible note, you should:

- [ ] **Model three conversion scenarios** at $5M, $10M, and $15M Series A valuations. Calculate founder dilution in each scenario.
- [ ] **Map all existing SAFEs and convertibles** with terms, caps, discounts, and MFN status.
- [ ] **Calculate aggregate dilution** from all seed instruments at your expected Series A valuation. Compare to your target founder ownership (most target 65-75% post-Series A).
- [ ] **Identify any MFN trigger risks.** If you're about to issue a convertible with a deeper discount, will existing SAFEs auto-convert at the new rate?
- [ ] **Align conversion triggers** with your realistic fundraising timeline. Build in 3-6 month buffer.
- [ ] **Document your cap table assumptions** in writing. When Series A closes, you'll have clarity on what was modeled vs. what actually happened.

## Moving Forward: From Reset to Strategy

The cap table reset problem isn't a reason to avoid SAFEs or convertibles—it's a reason to be intentional about them.

In our work with startups at [Fractional CFO Timing: The Revenue Threshold Most Founders Miss](/blog/fractional-cfo-timing-the-revenue-threshold-most-founders-miss/), we've found that founders who nail their cap table strategy early—before seed rounds—have dramatically cleaner Series A negotiations. They understand their actual dilution. They know exactly how much equity they have to allocate to employees and future rounds. And they're not surprised by the conversion math.

The founders who struggle are the ones who accumulate SAFEs and convertibles without modeling the downstream impact, then face cap table resets at Series A that fundamentally change their negotiating position.

Don't be in the second group. Model the reset before it happens. Your Series A self will thank you.

---

## Get Your Cap Table in Order

If you're raising seed capital and haven't modeled your SAFE and convertible conversion scenarios, now's the time. At Inflection CFO, we help founders understand the true cost of early-stage fundraising instruments before they commit.

[Schedule a free financial audit](/contact) to review your cap table strategy and ensure you understand the reset mechanics of your existing instruments.